Xie, M., Vesuna, F., Botlagunta, M., Bol, G. M., Irving, A., Bergman, Y., . . . Raman, V. (2015). NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3. Oncotarget.
Citação norma ChicagoXie, Min, et al. "NZ51, a Ring-expanded Nucleoside Analog, Inhibits Motility and Viability of Breast Cancer Cells By Targeting the RNA Helicase DDX3." Oncotarget 2015.
MLA CitationXie, Min, et al. "NZ51, a Ring-expanded Nucleoside Analog, Inhibits Motility and Viability of Breast Cancer Cells By Targeting the RNA Helicase DDX3." Oncotarget 2015.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.